Veracyte
Price & Volume
Stats
See moreOpen | $43.45 |
Previous Close | $43.60 |
Day Range | $43.43-$44.28 |
52W Range | $18.61-$46 |
Market Cap | $3.3B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $425.3M |
Revenue Growth (YoY) | 28.6% |
Gross Profit (12 Mos) | $296.9M |
Diluted EPS | -$0.14 |
News
See moreYahoo Finance • 4 months ago
New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
Yahoo Finance • 9 months ago
Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount?
Yahoo Finance • 9 months ago
Q1 2024 Veracyte Inc Earnings Call
Yahoo Finance • 9 months ago
Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024
About
CEO | Mr. Marc A. Stapley |
CFO | Ms. Rebecca Chambers |
Address | 6000 Shoreline Court, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 815 |
